AnaCardio

Healthcare & Life Sciences

Recent Finacing

Recent Raise

AnaCardio is a biopharmaceutical company developing an oral ghrelin receptor agonist to treat heart failure with reduced ejection fraction.

Total Funding

Headquarters

Founded

Website

Focus Areas

Biopharmaceutical

Heart Failure

Drug Development

Clinical Trials

Ghrelin Receptor Agonist

Cardiac Contractility

Investors